Meta AnalysisID 6341
清暑益气汤辅助治疗德尔塔变异株COVID-19的临床疗效与安全性：系统评价与Meta分析方案
CRD42021271606
What are the effects of Chinese medicine interventions in improving patients with COVID-19 of the Delta variant? We aim to generate a clinically useful summary of the interventions based on their efficacy.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6341
- Evidence Id
- 14899
- Core Evidence Id
- 14899
- Source Meta Analysis Id
- 6325
- Herb2 Meta Analysis Id
- HBMA006325
- Crd Id
- CRD42021271606
- Title
- Clinical efficacy and safety of Qingshu Yiqi decoction as a complementary and alternative therapy for COVID-19 with Delta variant: A protocol for systematic review and meta-analysis
- Review Question
- What are the effects of Chinese medicine interventions in improving patients with COVID-19 of the Delta variant? We aim to generate a clinically useful summary of the interventions based on their efficacy.
- Study Type Included
- Randomized controlled trials (RCTs) will be included.
- Condition Being Studied
- The novel coronavirus pneumonia has brought great harm and loss to the world since its outbreak. After sequencing, it is known to be caused by a novel coronavirus SARS-CoV-2. Delta variant is more infectious and dangerous, which can cause severe case eaisly. At present, the main treatment strategy is conventional drugs in new use. Screening anti-virus and anti-excessive immune response drugs to conduct related researches. Chinese medicine has played a pivotal role in the anti-epidemic process, and give a new strategy to this new variant.
- Participant
- Adults with COVID-19 of the Delta variant.
- Animal
- Human Disease Modelled
- Intervention
- Chinese medicine is the main intervention.
- Comparator Control
- Conventional symptomatic and supportive treatment.
- Main Outcome
- Total effective rate; TCM (traditional Chinese medicine) syndrome score; NAT (nucleic acid amplification technique) negative conversion rate.
- Outcome Measure
- Additional Outcome
- WBC (white blood cells); CRP (C-reactive proteins); lymphocytes.
- Study Method
- Intervention, Meta-analysis, Systematic review
- Keyword
- Adult; COVID-19; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Treatment Outcome
- Contact
- Yu Xia [email protected]
- Organisational Affiliation
- Hunan University of Chinese Medicine
- Funding Source
- The Hunan Provincial Science and Technology Department project (no. 2020SK3034); the Project of National Natural Science Foundation of China (no. 81803993)
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2021-08-03
- Registration Date
- 2021-08-03
- Anticipated Start Date
- 2021-08-01
- Anticipated Completion Date
- 2021-10-11
- Title Cn
- 清暑益气汤辅助治疗德尔塔变异株COVID-19的临床疗效与安全性：系统评价与Meta分析方案
- Title En
- Clinical efficacy and safety of Qingshu Yiqi decoction as a complementary and alternative therapy for COVID-19 with Delta variant: A protocol for systematic review and meta-analysis
- Bilingual Status
- complete